Neurocrine Biosciences, Inc.
- NBIX
- NASDAQ
- Biotechnology
- Neurology/CNS Drugs
- Endocrine/Psychiatry
- Specialty Pharmaceuticals
$135.09
Today −0.45%Quote Oct 19, 2026, 02:05 PM UTC
−10.62%over the last month
Max drawdown −11.0%From 1-month high −10.6%3 months −21.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$13.73B
Quote Oct 19
Next earnings
Nov 2
Expected, not confirmed
Analyst target
$204.18
+51.1% from here
Floor
$133.46
1.2% below price
Where the price sits
37 analysts
Analyst range, low to high
$165.00$230.00
- Price $135.09
- Resistance $135.93–$137.29
- Consensus $204.18
The price is just above its floor and right under resistance. Analysts' average target sits about 51% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NBIXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
2,500
Founded
1992